Today reported financial results for its third quarter ended September 30, 2025. Revenues were $121,548, an increase of $29,285 or 32% over the same period in prior year. Net loss was $3,791, compared to a net income of $85 in the same period in prior year. Knight Therapeutics Inc. shares T.GUD are trading up $0.24 at $6.08.
Stocks in play: Knight Therapeutics Inc.
Baystreet.ca
-
Baystreet -
Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
/Microsoft%20Corporation%20logo%20on%20sign-by%20Jean-Luc%20Ichard%20via%20iStock.jpg)
/ServiceNow%20Inc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)